Circadian control of hepatitis B virus replication
Chronic hepatitis B virus (HBV) infection is a major cause of liver disease and cancer worldwide for which there are no curative therapies. The major challenge in curing infection is eradicating or silencing the covalent closed circular DNA (cccDNA) form of the viral genome. The circadian factors BM...
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Sprache: | English |
Veröffentlicht: |
Springer Nature
2021
|
_version_ | 1826293501042622464 |
---|---|
author | Zhuang, X Forde, D Tsukuda, S D'arienzo, V Mailly, L Harris, JM Wing, PAC Borrmann, H Schilling, M Magri, A Orbegozo Rubio, C Maidstone, RJ Iqbal, M Garzon, M Minisini, R Pirisi, M Butterworth, S Balfe, P Ray, DW Watashi, K Baumert, TF McKeating, J |
author_facet | Zhuang, X Forde, D Tsukuda, S D'arienzo, V Mailly, L Harris, JM Wing, PAC Borrmann, H Schilling, M Magri, A Orbegozo Rubio, C Maidstone, RJ Iqbal, M Garzon, M Minisini, R Pirisi, M Butterworth, S Balfe, P Ray, DW Watashi, K Baumert, TF McKeating, J |
author_sort | Zhuang, X |
collection | OXFORD |
description | Chronic hepatitis B virus (HBV) infection is a major cause of liver disease and cancer worldwide for which there are no curative therapies. The major challenge in curing infection is eradicating or silencing the covalent closed circular DNA (cccDNA) form of the viral genome. The circadian factors BMAL1/CLOCK and REV-ERB are master regulators of the liver transcriptome and yet their role in HBV replication is unknown. We establish a circadian cycling liver cell-model and demonstrate that REV-ERB directly regulates NTCP-dependent hepatitis B and delta virus particle entry. Importantly, we show that pharmacological activation of REV-ERB inhibits HBV infection in vitro and in human liver chimeric mice. We uncover a role for BMAL1 to bind HBV genomes and increase viral promoter activity. Pharmacological inhibition of BMAL1 through REV-ERB ligands reduces pre-genomic RNA and de novo particle secretion. The presence of conserved E-box motifs among members of the Hepadnaviridae family highlight an evolutionarily conserved role for BMAL1 in regulating this family of small DNA viruses. |
first_indexed | 2024-03-07T03:31:04Z |
format | Journal article |
id | oxford-uuid:babc5fd1-80c1-4363-823a-8ddc82bb136a |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-07T03:31:04Z |
publishDate | 2021 |
publisher | Springer Nature |
record_format | dspace |
spelling | oxford-uuid:babc5fd1-80c1-4363-823a-8ddc82bb136a2022-03-27T05:11:59ZCircadian control of hepatitis B virus replicationJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:babc5fd1-80c1-4363-823a-8ddc82bb136aEnglishSymplectic ElementsSpringer Nature2021Zhuang, XForde, DTsukuda, SD'arienzo, VMailly, LHarris, JMWing, PACBorrmann, HSchilling, MMagri, AOrbegozo Rubio, CMaidstone, RJIqbal, MGarzon, MMinisini, RPirisi, MButterworth, SBalfe, PRay, DWWatashi, KBaumert, TFMcKeating, JChronic hepatitis B virus (HBV) infection is a major cause of liver disease and cancer worldwide for which there are no curative therapies. The major challenge in curing infection is eradicating or silencing the covalent closed circular DNA (cccDNA) form of the viral genome. The circadian factors BMAL1/CLOCK and REV-ERB are master regulators of the liver transcriptome and yet their role in HBV replication is unknown. We establish a circadian cycling liver cell-model and demonstrate that REV-ERB directly regulates NTCP-dependent hepatitis B and delta virus particle entry. Importantly, we show that pharmacological activation of REV-ERB inhibits HBV infection in vitro and in human liver chimeric mice. We uncover a role for BMAL1 to bind HBV genomes and increase viral promoter activity. Pharmacological inhibition of BMAL1 through REV-ERB ligands reduces pre-genomic RNA and de novo particle secretion. The presence of conserved E-box motifs among members of the Hepadnaviridae family highlight an evolutionarily conserved role for BMAL1 in regulating this family of small DNA viruses. |
spellingShingle | Zhuang, X Forde, D Tsukuda, S D'arienzo, V Mailly, L Harris, JM Wing, PAC Borrmann, H Schilling, M Magri, A Orbegozo Rubio, C Maidstone, RJ Iqbal, M Garzon, M Minisini, R Pirisi, M Butterworth, S Balfe, P Ray, DW Watashi, K Baumert, TF McKeating, J Circadian control of hepatitis B virus replication |
title | Circadian control of hepatitis B virus replication |
title_full | Circadian control of hepatitis B virus replication |
title_fullStr | Circadian control of hepatitis B virus replication |
title_full_unstemmed | Circadian control of hepatitis B virus replication |
title_short | Circadian control of hepatitis B virus replication |
title_sort | circadian control of hepatitis b virus replication |
work_keys_str_mv | AT zhuangx circadiancontrolofhepatitisbvirusreplication AT forded circadiancontrolofhepatitisbvirusreplication AT tsukudas circadiancontrolofhepatitisbvirusreplication AT darienzov circadiancontrolofhepatitisbvirusreplication AT maillyl circadiancontrolofhepatitisbvirusreplication AT harrisjm circadiancontrolofhepatitisbvirusreplication AT wingpac circadiancontrolofhepatitisbvirusreplication AT borrmannh circadiancontrolofhepatitisbvirusreplication AT schillingm circadiancontrolofhepatitisbvirusreplication AT magria circadiancontrolofhepatitisbvirusreplication AT orbegozorubioc circadiancontrolofhepatitisbvirusreplication AT maidstonerj circadiancontrolofhepatitisbvirusreplication AT iqbalm circadiancontrolofhepatitisbvirusreplication AT garzonm circadiancontrolofhepatitisbvirusreplication AT minisinir circadiancontrolofhepatitisbvirusreplication AT pirisim circadiancontrolofhepatitisbvirusreplication AT butterworths circadiancontrolofhepatitisbvirusreplication AT balfep circadiancontrolofhepatitisbvirusreplication AT raydw circadiancontrolofhepatitisbvirusreplication AT watashik circadiancontrolofhepatitisbvirusreplication AT baumerttf circadiancontrolofhepatitisbvirusreplication AT mckeatingj circadiancontrolofhepatitisbvirusreplication |